Prana Alzheimers disease Development Program update
Filed with ASX ·
6ix hasn’t read this filing yet.
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
- Appendix 4D Half Yearly Report and Accounts
- Appendix 4E and Annual Report 2015
- Trial presented at World Congress on Huntington`s Disease
- Share Purchase Plan 2013 Offer Document
- Safety Outcomes of Alzheimers IMAGINE Extension Trial
Later from Alterity Therapeutics
- Appendix 4E Preliminary Final Report and Statutory Accounts
- Parkinsons UK Awards GBP150,000 to Study Pranas PBT434
- Prana completes PBT2 dosing in IMAGINE AD Trial
- Prana Provides Update on Clinical Trials for Alzheimers
- Pranas PBT2 Reverses Memory Loss in Normal Aging
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics